GlassScriptPhysician profile
Alexandra Muranova
NPI 1083276323
$1,475.76
in general payments reported to CMS, 2019-2025
22 companies · $47.37 in 2025
The $47.37 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.89 · 2020: $43.51 · 2022: $490 · 2023: $658 · 2024: $222 · 2025: $47.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $227.43 | 2022-2023 | |
| Abbvie INC. | $142.32 | 2023-2025 | |
| Neurelis, INC. | $139.34 | 2023-2024 | Valtoco |
| Alexion Pharmaceuticals, INC. | $127.53 | 2022-2023 | Soliris, Ultomiris |
| Amneal Pharmaceuticals LLC | $119.96 | 2023 | Rytary |
| Tanabe Pharma America, INC. | $95.11 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $91.18 | 2022-2023 | |
| Eisai INC. | $78.01 | 2023 | |
| Biogen, INC. | $67.73 | 2022-2023 | Tysabri, Vumerity |
| Ucb, INC. | $57.89 | 2022 | |
| Acorda Therapeutics, INC | $47.82 | 2022-2023 | Inbrija |
| Merz Pharmaceuticals, LLC | $43.28 | 2023 | Xeomin |
| Livanova USA, INC. | $37.14 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Argenx US, INC. | $36.02 | 2023 | Vyvgart |
| Csl Behring | $31.82 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $28.97 | 2022 | |
| Sumitomo Pharma America, INC. | $21.65 | 2023 | Aptiom |
| Emd Serono, INC. | $19.75 | 2022 | |
| Acadia Pharmaceuticals INC | $19.63 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $16.60 | 2023 | Fycompa |
| Medtronic USA, INC. | $14.89 | 2019 | |
| Pfizer INC. | $11.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Muranova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.